252 related articles for article (PubMed ID: 18330936)
1. Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells.
Pinmai K; Chunlaratthanabhorn S; Ngamkitidechakul C; Soonthornchareon N; Hahnvajanawong C
World J Gastroenterol; 2008 Mar; 14(10):1491-7. PubMed ID: 18330936
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibitory effects of Phyllanthus niruri extracts in combination with cisplatin on cancer cell lines.
Araújo RF; Soares LA; da Costa Porto CR; de Aquino RG; Guedes HG; Petrovick PR; de Souza TP; Araújo AA; Guerra GC
World J Gastroenterol; 2012 Aug; 18(31):4162-6168. PubMed ID: 22919249
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antiplasmodial activity and cytotoxicity of water extracts of Phyllanthus emblica, Terminalia chebula, and Terminalia bellerica.
Pinmai K; Hiriote W; Soonthornchareonnon N; Jongsakul K; Sireeratawong S; Tor-Udom S
J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S120-6. PubMed ID: 21294406
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Growth Inhibitory Effects of Eryngium kotschyi Extracts with Conventional Cytotoxic Agents: Cisplatin and Doxorubicin against Human Endometrium Cancer Cells.
Karaboğa Arslan AK; Paşayeva L; Esen MA; Tugay O
Curr Pharm Biotechnol; 2022; 23(5):740-748. PubMed ID: 34445948
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase.
el-Mekkawy S; Meselhy MR; Kusumoto IT; Kadota S; Hattori M; Namba T
Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):641-8. PubMed ID: 7541317
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the Cytotoxic Activity of Triphala: A Semisolid Traditional Formulation on HepG
Sahragard A; Alavi Z; Abolhassanzadeh Z; Moein M; Mohammadi-Bardbori A; Omidi M; Zarshenas MM
Biomed Res Int; 2021; 2021():6689568. PubMed ID: 34471640
[TBL] [Abstract][Full Text] [Related]
7. Synergistic cytotoxicity of red beetroot (Beta vulgaris L.) extract with doxorubicin in human pancreatic, breast and prostate cancer cell lines.
Kapadia GJ; Rao GS; Ramachandran C; Iida A; Suzuki N; Tokuda H
J Complement Integr Med; 2013 Jun; 10():. PubMed ID: 23828331
[TBL] [Abstract][Full Text] [Related]
8. Phyllanthus emblica Linn. fruit extract potentiates the anticancer efficacy of mitomycin C and cisplatin and reduces their genotoxicity to normal cells in vitro.
Guo XH; Ni J; Xue JL; Wang X
J Zhejiang Univ Sci B; 2017 Dec.; 18(12):1031-1045. PubMed ID: 29204983
[TBL] [Abstract][Full Text] [Related]
9. In vitro antioxidant and inhibitory potential of Terminalia bellerica and Emblica officinalis fruits against LDL oxidation and key enzymes linked to type 2 diabetes.
Nampoothiri SV; Prathapan A; Cherian OL; Raghu KG; Venugopalan VV; Sundaresan A
Food Chem Toxicol; 2011 Jan; 49(1):125-31. PubMed ID: 20951180
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
[TBL] [Abstract][Full Text] [Related]
11. Granulin A Synergizes with Cisplatin to Inhibit the Growth of Human Hepatocellular Carcinoma.
Qiao G; Xu H; Li C; Li X; Farooqi AA; Zhao Y; Liu X; Liu M; Stagos D; Lin X
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301274
[TBL] [Abstract][Full Text] [Related]
12. Ellagic acid synergistically potentiates inhibitory activities of chemotherapeutic agents to human hepatocellular carcinoma.
Zhong C; Qiu S; Li J; Shen J; Zu Y; Shi J; Sui G
Phytomedicine; 2019 Jun; 59():152921. PubMed ID: 31055231
[TBL] [Abstract][Full Text] [Related]
13. Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells.
El-Daly SM; Gouhar SA; Gamal-Eldeen AM; Abdel Hamid FF; Ashour MN; Hassan NS
Anticancer Agents Med Chem; 2019; 19(18):2197-2210. PubMed ID: 31566136
[TBL] [Abstract][Full Text] [Related]
14. Synergistic anti-cancer effects of grape seed extract and conventional cytotoxic agent doxorubicin against human breast carcinoma cells.
Sharma G; Tyagi AK; Singh RP; Chan DC; Agarwal R
Breast Cancer Res Treat; 2004 May; 85(1):1-12. PubMed ID: 15039593
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
Dong X; Liu F; Li M
Anticancer Drugs; 2016 Apr; 27(4):286-99. PubMed ID: 26704389
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression.
Notarbartolo M; Poma P; Perri D; Dusonchet L; Cervello M; D'Alessandro N
Cancer Lett; 2005 Jun; 224(1):53-65. PubMed ID: 15911101
[TBL] [Abstract][Full Text] [Related]
17. Influence of Emblica officinalis aqueous extract on growth and antioxidant defense system of human hepatoma cell line (HepG2).
Shivananjappa MM; Joshi MK
Pharm Biol; 2012 Apr; 50(4):497-505. PubMed ID: 22133060
[TBL] [Abstract][Full Text] [Related]
18. Caspase mediated synergistic effect of Boswellia serrata extract in combination with doxorubicin against human hepatocellular carcinoma.
Khan MA; Singh M; Khan MS; Najmi AK; Ahmad S
Biomed Res Int; 2014; 2014():294143. PubMed ID: 25177685
[TBL] [Abstract][Full Text] [Related]
19. Chebulagic acid synergizes the cytotoxicity of doxorubicin in human hepatocellular carcinoma through COX-2 dependant modulation of MDR-1.
Achari C; Reddy GV; Reddy TC; Reddanna P
Med Chem; 2011 Sep; 7(5):432-42. PubMed ID: 21801152
[TBL] [Abstract][Full Text] [Related]
20. Progallin A isolated from the acetic ether part of the leaves of Phyllanthus emblica L. induces apoptosis of human hepatocellular carcinoma BEL-7404 cells by up-regulation of Bax expression and down-regulation of Bcl-2 expression.
Zhong ZG; Wu DP; Huang JL; Liang H; Pan ZH; Zhang WY; Lu HM
J Ethnopharmacol; 2011 Jan; 133(2):765-72. PubMed ID: 21073944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
